Tag: Prostate ablation
Randomised trial demonstrates MRI-guided TULSA benefit for intermediate-risk prostate cancer
A new randomised controlled trial found that men with localised, intermediate‑risk prostate cancer recovered faster and experienced less short‑term impact on their daily lives...
Study shows “significant” PSA reduction with cryoablation for recurrent prostate cancer
An 11-year prospective study of magnetic resonance (MR)-guided cryoablation in the treatment of recurrent cancer in the prostate bed has demonstrated “significant” prostate-specific antigen...
AngioDynamics receives FDA clearance for prostate tissue ablation system
AngioDynamics has announced that it has received US Food and Drug Administration (FDA) 510(k) clearance for the NanoKnife system for prostate tissue ablation.
The company received clearance...
